Company: PSTV
Filing Date: 2025-05-23
Form Type: 8-K
Source: 0001193125-25-125860
Chunk: 0

Company: PLUS THERAPEUTICS, INC.
Filing Date: 2025-05-23
Form: 8-K
Item: Item 3.01
Chunk 0
---
Item 3.01.      Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.  

On May 21, 2025, Plus Therapeutics, Inc. (the “ Company”) received a notice (the “ Notice”) from the Nasdaq Stock Market LLC (“ Nasdaq”), which indicated that, as a result of the Company’s delay in filing its Quarterly Report on Form10-Qfor the period ended March 31, 2025 (the “ Quarterly Report”), the Company was not in compliance with Nasdaq Listing Rule 5250(c)(1) (the “ Rule”), which requires Nasdaq-listed companies to timely file all required periodic financial reports with the U. S. Securities and Exchange Commission (the “ SEC”).

The Notice states that the Company has until July 21, 2025, to submit to Nasdaq an update to its plan to regain compliance with the Rule. The Notice also indicates that any additional exception to allow the Company to regain compliance with all delinquent filings will be limited to up to 180 calendar days from the due date of the filing, or until November 17, 2025. The Notice has no immediate effect on the listing of the Company’s securities on Nasdaq.

The Company continues to work diligently to complete its Quarterly Report and plans to file its Quarterly Report as promptly as possible to regain compliance with the Rule.